Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial

Neelapu, Sattva S ; Dickinson, Michael ; Munoz, Javier ; Ulrickson, Matthew L ; Thieblemont, Catherine ; Oluwole, Olalekan O ; Herrera, Alex F ; Ujjani, Chaitra S ; Lin, Yi ; Riedell, Peter A ; Kekre, Natasha ; de Vos, Sven ; Lui, Christine ; Milletti, Francesca ; Dong, Jinghui ; Xu, Hairong ; Chavez, Julio C

Nature medicine, 2022-04, Vol.28 (4), p.735-742 [Periódico revisado por pares]

United States: Nature Publishing Group

Texto completo disponível